Optimizerx (OPRX) closed at $9.15 on October 23, 2026, up 0.8% from the previous close, on volume of 76,381 shares (30-day average 161,460).
Data as of October 23, 2026.
23-Oct-2026
OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath
Globe Newswire (Tue, 22-Sep 8:00 AM ET)
OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence
Globe Newswire (Mon, 14-Sep 8:00 AM ET)
OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
Globe Newswire (Tue, 8-Sep 7:30 AM ET)
OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor
Globe Newswire (Wed, 2-Sep 7:30 AM ET)
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
Globe Newswire (Wed, 12-Aug 4:05 PM ET)
OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
Globe Newswire (Wed, 12-Aug 4:01 PM ET)
OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET
Globe Newswire (Wed, 29-Jul 7:30 AM ET)
OptimizeRx Achieves Rule of 40 Status Amid Record 2025 Performance and $10 Million Share Buyback
Market Chameleon (Fri, 6-Mar 2:50 AM ET)
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
Optimizerx trades on the NASDAQ stock market under the symbol OPRX.
As of October 23, 2026, OPRX stock price climbed to $9.15 with 76,381 million shares trading.
OPRX has a beta of 2.28, meaning it tends to be more sensitive to market movements. OPRX has a correlation of 0.16 to the broad based SPY ETF.
OPRX has a market cap of $169.19 million. This is considered a Micro Cap stock.
Last quarter Optimizerx reported $21 million in Revenue and $.16 earnings per share. This beat revenue expectation by $244,800 and exceeded earnings estimates by $.07.
In the last 3 years, OPRX traded as high as $22.25 and as low as $3.78.
The top ETF exchange traded funds that OPRX belongs to (by Net Assets): VTI, DFSV, VXF, IWC, ITOT.
OPRX has underperformed the market in the last year with a return of -53.3%, while SPY returned +14.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in OPRX shares. However, OPRX has outperformed the market in the last 3 month and 2 week periods, returning +47.3% and +10.5%, while SPY returned +3.2% and -2.4%, respectively. This indicates OPRX has been having a stronger performance recently.
OPRX support price is $8.74 and resistance is $9.42 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OPRX shares will trade within this expected range on the day.